tiprankstipranks
Stoke Therapeutics Inc (STOK)
NASDAQ:STOK
US Market

Stoke Therapeutics (STOK) Income Statement

Compare
353 Followers

Stoke Therapeutics Income Statement

Last quarter (Q3 2024), Stoke Therapeutics's total revenue was $4.89M, an increase of 47.94% from the same quarter last year. In Q3, Stoke Therapeutics's net income was $-26.43M. See Stoke Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 8.78M$ 12.40M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 8.78M$ 8.87M$ -2.23M$ -1.93M$ -450.00K
Operating Expenses
$ 123.55M$ 116.76M$ 86.06M$ 53.04M$ 35.68M
Depreciation and Amortization
$ 2.47M$ 3.54M$ 2.23M$ 1.93M$ 450.00K
EBITDA
$ -112.30M$ -102.81M$ -83.58M$ -50.32M$ -35.23M
Operating Income
$ -114.77M$ -104.36M$ -86.06M$ -53.04M$ -35.68M
Other Income/Expenses
$ 10.07M$ 3.29M$ 260.00K$ 801.00K$ 3.35M
Pretax Income
$ -104.70M$ -101.07M$ -85.81M$ -52.24M$ -32.33M
Net Income
$ -104.70M$ -93.11M$ -84.71M$ -50.61M$ -28.52M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.38$ -2.39$ -2.31$ -1.51$ -1.59
Diluted EPS
$ -2.38$ -2.39$ -2.31$ -1.51$ -1.59
Weighted Average Shares Outstanding
43.99M 38.90M 36.74M 33.49M 17.97M
Weighted Average Shares Outstanding (Diluted)
43.99M 38.90M 36.74M 33.49M 17.97M
Currency in USD

Stoke Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis